# Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography

> **NCT00704561** · NA · COMPLETED · sponsor: **A.O. Ospedale Papa Giovanni XXIII** · enrollment: 44 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DEVICE:** ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA)
- **DEVICE:** DRIVER bare metal stent (Medtronic, Santa Rosa, Ca)
- **DEVICE:** Coronary stent implantation
- **DEVICE:** Bare Metal Coronary Stent

## Key facts

- **NCT ID:** NCT00704561
- **Lead sponsor:** A.O. Ospedale Papa Giovanni XXIII
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-10
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-05-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704561, "Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00704561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*